Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midostaurin in Indolent or Smoldering Systemic Mastocytosis
NCT01920204Phase 2Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midostaurin in indolent systemic mastocytosis (ISM), smoldering systemic mastocytosis (SSM), sponsored by University Medical Center Groningen. Status: unknown.
02
Drugs
midostaurin
03
Conditions
indolent systemic mastocytosis (ISM)smoldering systemic mastocytosis (SSM)
Beyond the preview
Go deeper on NCT01920204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01920204.